Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder.

about

Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder.

Item

http://www.wikidata.org/entity/Q47573914

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Vortioxetine versus placebo in ...... with social anxiety disorder.

@en

Vortioxetine versus placebo in ...... with social anxiety disorder.

@nl

type

Item

label

Vortioxetine versus placebo in ...... with social anxiety disorder.

@en

Vortioxetine versus placebo in ...... with social anxiety disorder.

@nl

prefLabel

Vortioxetine versus placebo in ...... with social anxiety disorder.

@en

Vortioxetine versus placebo in ...... with social anxiety disorder.

@nl

P1476

Vortioxetine versus placebo in ...... d with social anxiety disorder

@en

P2093

Jason Careri

http://www.w3.org/2001/XMLSchema#string

Junko Morita

http://www.w3.org/2001/XMLSchema#string

Kyra Blatt

http://www.w3.org/2001/XMLSchema#string

Melissa Moran

http://www.w3.org/2001/XMLSchema#string

Michael R Liebowitz

http://www.w3.org/2001/XMLSchema#string

Rita Hanover

http://www.w3.org/2001/XMLSchema#string

P2860

The assessment of anxiety states by rating

A new depression scale designed to be sensitive to change

Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults.

Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life.

Vortioxetine (Lu AA21004) in generalized anxiety disorder: results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial.

Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States.

Pharmacological treatment of social anxiety disorder: a meta-analysis.

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.

P304

1164-1172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DA.22702

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ann Draine

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29166552

http://www.w3.org/2001/XMLSchema#string

P921

placebo